Finance

Lists
SKNY:CNSX
LIR Life Sciences Corp
0,20 CA$
0,00%
(0,00) 1D
13 қаз., 12:45:20 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for SKNY...
Mkt. cap
5,73 млн
Avg. vol.
17,86 мың
Volume
0,00
52-wk high
2,41 CA$
52-wk low
0,10 CA$
EPS
-0,18 CA$
Mkt. cap
5,73 млн
Avg. vol.
17,86 мың
Volume
0,00
52-wk high
2,41 CA$
52-wk low
0,10 CA$
EPS
-0,18 CA$
News stories
From web sources and news partners
About LIR Life Sciences Corp
CEO-
Employees-
Founded2018
HeadquartersВанкувер, Британдық Колумбия, Канада
SectorPharmaceutical industry
Websiteblackbirdmetals.ca
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
2025 ж. қаз.
2026 ж. қаң.
2026 ж. сәу.
2026 ж. шіл.
Revenue
-
-
-
-
Cost of goods sold
-
-
6,67 мың
5,00 мың
Cost of revenue
-
-
6,67 мың
5,00 мың
Research and development expenses
-
10,00 мың
52,10 мың
255,17 м.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
61,85 мың
1,13 млн
317,32 м.
323,37 м.
Operating expense
67,88 мың
1,87 млн
1,23 млн
981,44 м.
Total operating expenses
67,88 мың
1,87 млн
1,24 млн
986,44 м.
Operating income
-67,88 мың
-1,87 млн
-1,24 млн
-986,44 м.
Other non operating income
-6,52 мың
-343,44 м.
-57,71 мың
-3,70 мың
EBT including unusual items
-64,24 мың
-2,16 млн
-1,40 млн
-989,04 м.
EBT excluding unusual items
-196,00 м.
-2,21 млн
-1,30 млн
-989,04 м.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-64,24 мың
-2,16 млн
-1,40 млн
-989,04 м.
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
142,00
-
-
20,00
Interest expense
-
-
-
-
Net interest expenses
10,69 мың
-
-
20,00
Depreciation and amortization charges
-
-
1,28 мың
-
EBITDA
-64,40 мың
-1,87 млн
-1,24 млн
-985,20 м.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары